Kim Julie So-Young — SEC Form 4 filings

SEC reporting owner CIK 1977732. 3 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2026-04-28 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TAKEDA PHARMACEUTICAL CO LTD (TAK)President and CEO, Director31 leg · 89,090 sh · $1,523,4396

Form 4 filings — Kim Julie So-Young

FiledFormIssuerReported transactionsSource
2026-08-124TAKEDA PHARMACEUTICAL CO LTD (TAK)Sale (S): 89,090 @ $17.10EDGAR
2026-07-064TAKEDA PHARMACEUTICAL CO LTD (TAK)Grant/award (A): 50,434 @ $0 · Grant/award (A): 22,800 @ $0 · Grant/award (A): 7,741 (derivative) @ $0 · Grant/award (A): 7,741 (derivative) @ $0 · Grant/award (A): 7,743 (derivative) @ $0EDGAR
2026-04-284TAKEDA PHARMACEUTICAL CO LTD (TAK)Grant/award (A): 105,416 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1977732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →